Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trialJohn Chia, Han Chong Toh, Eva Segelov et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 34
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)Nizar M. Tannir, Oleg Karyakin, Maria Nirvana Formiga et al.|Journal of Clinical Oncology|2024Cited by 26
KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutationMichele Maio, Omid Hamid, Matteo S. Carlino et al.|European Journal of Cancer|2021Cited by 10
Implementation and evaluation of a smoking cessation checklist implemented within Australian cancer servicesAlison L. Young, Philip Beale, Nicole Rankin et al.|Asia-Pacific Journal of Clinical Oncology|2022Cited by 9
Nivolumab and Ipilimumab in Advanced Mismatch Repair–Deficient/Microsatellite Instability–High Noncolorectal CancersMatteo S. Carlino, Oliver Klein, Damien Kee et al.|JAMA Oncology|2025Cited by 5